​

Citius Pharmaceuticals (CTXR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Citius Pharmaceuticals Revenue Highlights

00

Citius Pharmaceuticals Revenue by Period

Citius Pharmaceuticals Revenue by Year

DateRevenueChange
2024-09-30-100.00%
2023-09-30-100.00%
2022-09-30-100.00%
2021-09-30-100.00%
2020-09-30-100.00%
2019-09-30-100.00%
2018-09-30-100.00%
2017-09-30-100.00%
2016-09-30-100.00%
2015-09-30-100.00%
2014-09-30-100.00%
2013-09-30-100.00%
2012-09-30-100.00%
2011-09-30--

Citius Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Citius Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-12-31--100.00%
2024-09-30$155.93K100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31--

Citius Pharmaceuticals generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Citius Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARDXArdelyx$333.62M$98.24M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
FBIOFortress Biotech$55.13M$14.63M
LXRXLexicon Pharmaceuticals$31.08M$1.74M
IBRXImmunityBio$14.74M$1.05M
BLRXBioLineRx$4.80M$6.86M
XFORX4 Pharmaceuticals$2.56M$560.00K
EYENEyenovia$3.79K$1.63K
CTXRCitius Pharmaceuticals--
MCRBSeres Therapeutics--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
HOOKHOOKIPA Pharma-$4.70M
MREOMereo BioPharma Group--

CTXR Revenue FAQ

What is Citius Pharmaceuticals’s yearly revenue?

Citius Pharmaceuticals's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. CTXR's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Citius Pharmaceuticals’s quarterly revenue?

Citius Pharmaceuticals's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $155.93K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). CTXR's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Citius Pharmaceuticals’s revenue growth rate?

Citius Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.